Lipid AA15
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
Lipid 331 is a biodegradable cyclic ionizable lipid. LNPs containing Lipid 331 result in robust transfection in the nasal and lung tissues of mice and efficient transfection of lung epithelial cells and lung-resident APCs. Lipid 331 is a promising candidate for mRNA vaccine delivery, offering the potential for further enhancing the potency of mRNA vaccines.
| Component | mol% | Role |
|---|---|---|
| Lipid 331 | 35 | Ionizable lipid |
| DOPE | 16 | Helper phospholipid |
| Cholesterol | 46.5 | Sterol |
| C14-PEG2000 | 2.5 | PEG lipid |
Process: aqueous mRNA and ethanol lipid phases mixed microfluidically at 3:1 aqueous:ethanol; final mRNA 0.1 mg/mL; dialysis against PBS overnight at 4 °C. Reported ionizable-lipid:mRNA mass ratio: 10:1.
Calculator disabled. N/P is not reported and C14-PEG2000 identity/MW is not sufficiently specified for component weighing. Do not convert the 10:1 mass ratio to N/P.
| Component | mol% | Role |
|---|---|---|
| Lipid 331 | 30 | Ionizable lipid |
| DOTAP | 39 | Cationic helper lipid |
| Cholesterol | 30 | Sterol |
| C14-PEG2000 | 1 | PEG lipid |
Used for the reported nasal/lung transfection and intranasal vaccine studies. N/P and lipid:mRNA mass ratio were not separately reported for this formulation.
Li B, Jiang AY, Raji I, et al. Nat Biomed Eng. 2025;9:167–184. DOI 10.1038/s41551-023-01082-6.
| CAS No. | Not available |
| Chemical Name | LIPID 331 |
| Synonyms | LIPID-331,LIPID331 |
| SMILES | O=C(OCCCCCCCC/C=C\C/C=C\CCCCC)CCCC1(CCCC(OCCCCCCCC/C=C\C/C=C\CCCCC)=O)C=NC(C(OC(C)(C)C)=O)N1CCN2CCCCC2CC |
| Formula | C61H107N3O6 |
| M.Wt | 978.52 |
| Purity | >95% |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA--Nature Biomedical Engineering (2023) |
This calculator uses the verified Lipid 331 molecular weight (978.52 g/mol) to prepare a standalone stock solution. It does not calculate LNP component masses or infer N/P.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 10.2195 mL | 2.0439 mL | 1.0220 mL |
| 25 mg | 25.5488 mL | 5.1098 mL | 2.5549 mL |
| 50 mg | 51.0976 mL | 10.2195 mL | 5.1098 mL |
| 100 mg | 102.1952 mL | 20.4390 mL | 10.2195 mL |
| 250 mg | 255.4879 mL | 51.0976 mL | 25.5488 mL |
Contact our team with the catalog number and requested quantity.